Overview

Positron Emission Tomography (PET) Study

Status:
Completed

Trial end date:
2009-08-01

Target enrollment:

Participant gender:

Summary

The primary purpose is to study the occupancy at the α4β2 neuronal nicotinic receptor's (NNRs) and to determine the relation between plasma concentration of AZD1446 and the occupancy at α4β2 NNRs.

Phase:

Phase 1

Details

Lead Sponsor:

AstraZeneca